Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery
Clinical trial NCT04620200 · COMPLETED
Trial details
- NCT number
- NCT04620200
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2025-01-07
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.